Dr. JD Ferwerda, MD
Dr. JD Ferwerda, MD: Dutch-trained ophthalmologist specialising in cataracts, lens exchange, retinal disease, glaucoma, and AMD.
Childhood myopia tends to get worse year by year until early adulthood; the faster it progresses, the higher the final prescription and the higher the lifetime risk of retinal complications. Modern myopia management uses evidence-based tools to slow that progression while a child's eyes are still growing.
In children, myopia rarely stands still. The set of tools below slows the eye's growth — so a child finishes at a lower final prescription, with a lower adult risk of sight-threatening changes.
How the eye grows, with and without management
Axial length of a myopic child's eye between ages 6 and 16.
Axial length (mm)
Age (years)
Myopia management uses three main tools, alone or in combination. Which one — or which mix — fits depends on your child’s age, prescription, axial length, family history and daily routine. That’s what the first assessment decides.
The earlier a child's myopia is being managed, the more years of progression there are to slow — and the more difference it makes by the time they stop growing.
Children and teenagers with actively progressing myopia — a prescription that is moving year on year
Children at higher risk of fast progression — early onset, both parents myopic, a fast first-year jump from no prescription to a real one
Children whose myopia is already at a level where future risk of retinal complications matters
Children who want to reduce daytime glasses dependence (Ortho-K is particularly suited to this)
Teenagers who haven't yet stabilised — progression often continues into the late teens
Not the right fit if: the patient is an adult with a stable prescription that hasn't moved in years — in that case the conversation moves to refractive surgery (LASIK, ICL, or RLE), not myopia control. Stable myopia in adulthood is corrected, not slowed.
Myopia management is paced for the child — structured first month, then routine quarterly checks, then an annual reassessment that compares axial length against the previous year.
Child-paced examination, full refraction, slit-lamp review, retinal screening, and axial-length measurement. The first visit is what every later visit is compared against.
Discussion of atropine, Ortho-K, and prescription glasses with myopia control lenses in context. The recommendation is built around the child's prescription, axial length, age, and routine.
Close review through the first month to confirm comfort and adherence. After that, quarterly or half-yearly checks track refraction and eyeball elongation.
A full reassessment with axial-length re-measurement every 6 months in the first years, then annually once axial length stabilises. The programme continues through the teenage years until the prescription stabilises.
Myopia management is a long programme, not a procedure. The reviews are how we know whether what we are doing is working.
Where your child is in the programme
Axial length is re-measured at each review and added to your child’s own curve. The dashed line is the projected trajectory without myopia control.
Months from starting
Close review of comfort, hygiene, and adherence with the chosen tool. Small adjustments to the routine if needed; questions answered ahead of the next quarterly check.
Mid-year refraction, biometry, and a check on the child's overall progress. Atropine dose or Ortho-K lens fit adjusted if the data calls for it.
Comparison of axial length against baseline tells us how much elongation the programme has prevented. Refraction, biometry, and a written summary follow.
The programme continues until myopia stabilises — usually somewhere between 16 and the early twenties. After that, the conversation shifts to long-term correction options.
Dr. JD Ferwerda, MD: Dutch-trained ophthalmologist specialising in cataracts, lens exchange, retinal disease, glaucoma, and AMD.
Russian-trained refractive and general ophthalmologist, leads lasik/ laser vision correction at EEC